Sunshine Insurance led a CNY600m (~USD96m) Series B for China-based biopharma Xuanzhu Biopharm, with participation from Efung Capital, Zhongji Investment, TJ Capital, SDIC Taikang, Haichuang FOF, Bank of China Capital, Jinjiang Xuanhong, Shanxi Financial Holdings, Wanxin Capital, DNV Capital and HY Capital. Read more